| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Division of Clinical Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania; 2 Division of Epidemiology and Community Health, University of Minnesota and 3 University of Minnesota Cancer Center, Minneapolis, Minnesota
Requests for reprints: Kathryn H. Schmitz, Division of Clinical Epidemiology University of Pennsylvania 423 Guardian Drive, 9th floor Blockley Drive, Philadelphia, PA 19072 215-898-0901 E-mail: kschmitz{at}cceb.upenn.edu
Background: This randomized controlled trial assessed the safety and effects of twice-weekly weight training among recent breast cancer survivors. Outcomes included body size and biomarkers hypothesized to link exercise and breast cancer risk.
Methods: A convenience sample of 85 recent survivors was randomized into immediate and delayed treatment groups. The immediate group trained from months 0 to 12; the delayed treatment group served as a no exercise parallel comparison group from months 0 to 6 and trained from months 7 to 12. Measures at baseline, 6 and 12 months included body weight, height, body fat, lean mass, body fat %, and waist circumference, as well as fasting glucose, insulin, insulin resistance, insulin-like growth factor-I (IGF-I), IGF-II, and IGF-binding protein-1, IGFBP-2, and IGFBP-3. Injury reporting was standardized.
Results: The intervention resulted in significant increases in lean mass (0.88 versus 0.02 kg, P < 0.01), as well as significant decreases in body fat % (–1.15% versus 0.23%, P = 0.03) and IGF-II (–6.23 versus 28.28 ng/mL, P = 0.02) comparing immediate with delayed treatment from baseline to 6 months. Within-person changes experienced by delayed treatment group participants during training versus no training were similar. Only one participant experienced a study related injury that prevented continued participation.
Conclusion: Twice-weekly weight training is a safe exercise program for recent breast cancer survivors that may result in increased muscle mass, as well as decreased body fat % and IGF-II. The implications of these results on cancer recurrence or survival may become more evident with longer exercise intervention trials among breast cancer survivors.
This article has been cited by other articles:
|
|
 |
|
  P. J. Goodwin Insulin in the Adjuvant Breast Cancer Setting: A Novel Therapeutic Target for Lifestyle and Pharmacologic Interventions? J. Clin. Oncol., February 20, 2008; 26(6): 833 - 834. [Full Text] [PDF]
|
|
|
|
|
|
J. A. Ligibel, N. Campbell, A. Partridge, W. Y. Chen, T. Salinardi, H. Chen, K. Adloff, A. Keshaviah, and E. P. Winer Impact of a Mixed Strength and Endurance Exercise Intervention on Insulin Levels in Breast Cancer Survivors J. Clin. Oncol., February 20, 2008; 26(6): 907 - 912. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S. Courneya, R. J. Segal, J. R. Mackey, K. Gelmon, R. D. Reid, C. M. Friedenreich, A. B. Ladha, C. Proulx, J. K.H. Vallance, K. Lane, et al. Effects of Aerobic and Resistance Exercise in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Multicenter Randomized Controlled Trial J. Clin. Oncol., October 1, 2007; 25(28): 4396 - 4404. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Daley, H. Crank, J. M. Saxton, N. Mutrie, R. Coleman, and A. Roalfe Randomized Trial of Exercise Therapy in Women Treated for Breast Cancer J. Clin. Oncol., May 1, 2007; 25(13): 1713 - 1721. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Mustian, G. R. Morrow, J. K. Carroll, C. D. Figueroa-Moseley, P. Jean-Pierre, and G. C. Williams Integrative Nonpharmacologic Behavioral Interventions for the Management of Cancer-Related Fatigue Oncologist, May 1, 2007; 12(suppl_1): 52 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Doyle, L. H. Kushi, T. Byers, K. S. Courneya, W. Demark-Wahnefried, B. Grant, A. McTiernan, C. L. Rock, C. Thompson, T. Gansler, et al. Nutrition and Physical Activity During and After Cancer Treatment: An American Cancer Society Guide for Informed Choices CA Cancer J Clin, November 1, 2006; 56(6): 323 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Visovsky Muscle strength, body composition, and physical activity in women receiving chemotherapy for breast cancer. Integr Cancer Ther, September 1, 2006; 5(3): 183 - 191. [Abstract] [PDF]
|
|
|
|
 |
|
 N. D. Eves and R. C. Plotnikoff Resistance Training and Type 2 Diabetes: Considerations for implementation at the population level Diabetes Care, August 1, 2006; 29(8): 1933 - 1941. [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. McNeely, K. L. Campbell, B. H. Rowe, T. P. Klassen, J. R. Mackey, and K. S. Courneya Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. Can. Med. Assoc. J., July 4, 2006; 175(1): 34 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Ahmed, W. Thomas, D. Yee, and K. H. Schmitz Randomized Controlled Trial of Weight Training and Lymphedema in Breast Cancer Survivors J. Clin. Oncol., June 20, 2006; 24(18): 2765 - 2772. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |
